.
MergerLinks Header Logo

New Deal


Announced

SD Biosensor to acquire Relab for $50m.

Financials

Edit Data
Transaction Value£41m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Private

Medical Equipment

Italy

Pending

Cross Border

Single Bidder

medical devices

Friendly

Acquisition

Majority

Synopsis

Edit

SD Biosensor, a manufacturer of COVID-19 test kits, agreed to acquire Relab, an Italian medical device distributor, for $50m.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US